Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: Acta Paediatr. 2021 Mar 8;110(7):2259–2266. doi: 10.1111/apa.15821

Appendix A1.

The odds ratios (OR) and 95% confidence intervals (CI) calculated, using conditional logistic regression modeling, as the ratio of the proportion of children exposed to maternal autoimmune disease and its medication in offspring with childhood cancer (cases) and the proportion of exposure to maternal autoimmune disease and its medication in healthy offspring (controls), 1996–2014. Both crude and adjusted ORs are presented. Stratified, unmatched analysis by sex and birth year.

N cases (%) N controls (%) Crude OR 95% CI Adj. OR 95% CI
No autoimmune disease 1.00 --- 1.00 ---
Any autoimmune disease 19 (0.9) 134 (1.3) 0.68 0.42–1.12 0.70 0.43–1.15
IBD 12 (0.6) 61 (0.6) 1.01 0.54–1.89 1.07 0.57–2.00
Rheumatic disease 7(0.3) 74 (0.7) 0.41 0.18–0.94 0.41 0.18–0.94
No AI medication purchases 1.00 --- 1.00 ---
Any AI medication purchase 169 (8.3) 888 (8.8) 0.95 0.80–1.13 0.96 0.80–1.14
IBD medication 13 (0.6) 65 (0.6) 1.01 0.56–1.84 1.07 0.59–1.95
Systemic corticosteroids 21(1.0) 107 (1.1) 0.91 0.56–1.49 0.93 0.57–1.52
Immunosuppressants 3 (0.1) 13 (0.1) 0.83 0.19–3.72 0.90 0.20–4.06
Anti-inflammatory and -rheumatic products 141 (6.9) 761 (7.5) 0.93 0.77–1.13 0.93 0.77–1.13
*

Stratified, unadjusted analysis

**

Stratified analysis adjusted for maternal age (categorized), parity and smoking status.